Chinese state fund invests in gene firm BGI
SYDNEY (Reuters) - The Chinese government has made an investment in BGI Genomics Co, a listed Chinese company that has supplied millions of COVID-19 tests globally as the gene firm seeks to fund exponential growth driven by the pandemic.
